文献速递骨质疏松与代谢性骨病创伤骨科

对二级骨折预防的依从性与后续骨折风险降低相关

Adherence to secondary fracture prevention is associated with reduced risk of subsequent fractures.
PubMed 文献 · Osteoporos Int · 2025-09-24

这项单中心质量评估研究纳入2015-2018年间1936例≥50岁且发生任何类型索引骨折的男女,比较骨折联络服务(FLS)就诊者1041例与非就诊者895例,以及开始抗骨质疏松药物(AOD)治疗12个月后依从者427例与非依从者174例。中位观察3.5年期间,就诊者后续骨折风险降低20%、死亡率降低33%,AOD依从者后续骨折风险降低49%,但死亡率无差异。

要点

  • FLS就诊者较非就诊者后续骨折风险降低20%(HR 0.80;95%CI 0.64-0.999),死亡率降低33%(HR 0.67;95%CI 0.51-0.89)。
  • AOD治疗12个月后依从者较非依从者后续骨折风险降低49%(HR 0.51;95%CI 0.35-0.72)。
  • AOD依从者与非依从者之间死亡率未见差异。

核心结论

  • 能够且愿意参加FLS的患者较非就诊者后续骨折和死亡风险更低。
  • AOD依从者较非依从者后续骨折风险更低,强调二级骨折预防中依从性的重要性。

研究设计与样本

  • 挪威捕获骨折倡议(Norwegian Capture the Fracture Initiative)的单中心子研究,纳入2015-2018年间1936例≥50岁且发生任何类型索引骨折的男女。
  • 比较FLS就诊者1041例与非就诊者895例,以及AOD治疗开始12个月后依从者427例与非依从者174例。
  • 模型校正年龄、性别、体质指数、吸烟、既往骨折和索引髋部骨折。

主要发现

  • 中位观察3.5年(范围0.5至6.3年),FLS就诊者较非就诊者任何类型后续骨折风险降低20%(HR 0.80;95%CI 0.64-0.999),死亡率降低33%(HR 0.67;95%CI 0.51-0.89)。
  • AOD治疗12个月后依从者较非依从者后续骨折风险降低49%(HR 0.51;95%CI 0.35-0.72)。
  • AOD依从者与非依从者之间未显示死亡率差异。

关键数值与推荐

  • FLS就诊者1041例 vs 非就诊者895例:后续任何类型骨折HR 0.80(95%CI 0.64-0.999),死亡率HR 0.67(95%CI 0.51-0.89)。
  • AOD治疗12个月后依从者427例 vs 非依从者174例:后续骨折HR 0.51(95%CI 0.35-0.72)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Attenders to fracture liaison services in a quality assessment study of 1936 women and men ≥ 50 years had 20% lower risk of subsequent fractures and 33% lower mortality than non-attenders. Patient's who were adherent to AOD after 12 months had a 49% lower risk of fractures than non-adherent patients. PURPOSE: Secondary fracture prevention rates are low in Norway and internationally. To overcome the existing treatment gap, fracture liaison services (FLS) are recommended. The study aimed to assess impact of FLS on fracture rates and mortality among attenders versus non-attenders, and patients adherent versus non-adherent to AOD. METHODS: This single-center sub-study of the Norwegian Capture the Fracture Initiative included 1936 women and men ≥ 50 years of age with an index fracture of any type during 2015-2018. We estimated hazard ratios (HR) for subsequent fractures and mortality in 1041 attenders versus 895 non-attenders to the FLS, and 427 patients who were adherent versus 174 patients who were non-adherent to anti-osteoporotic drugs (AOD) 12 months after treatment initiation. RESULTS: During a median 3.5-years observation (range 0.5 to 6.3), attenders had a 20% lower risk of subsequent fractures of any type (HR 0.80; 95% CI 0.64-0.999) and 33% lower mortality (HR 0.67; 95% CI 0.51-0.89) than non-attenders. Patients who were adherent to AOD after 12 months had a 49% lower risk of subsequent fractures than non-adherent patients (HR 0.51; 95% CI 0.35-0.72), but no difference in mortality was shown. Models were adjusted for age, sex, body mass index, smoking, prior fracture, and index hip fracture. CONCLUSION: These results confirm that patients who were able and willing to attend FLS had lower risk of subsequent fractures and mortality than non-attenders. Patients who were adherent to AOD had lower risk of subsequent fractures than non-adherent patients, emphasizing the importance of adherence in secondary fracture prevention.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Bjørnerem Å, Khoshkhabari J, Hansen AK, et al. Adherence to secondary fracture prevention is associated with reduced risk of subsequent fractures. Osteoporos Int. 2025. PMID: 40993438. doi:10.1007/s00198-025-07697-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。